Lilly(Eli) (LLY) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Banco Santander S.A. raised its position in Eli Lilly and Company (NYSE: LLY) by 48.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 178,190…

Eli Lilly and Co. (LLY) agreed to acquire Calytrix Bio for up to $1.5 billion in cash. The total includes an upfront payment and further payments tied to clinic…

Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.…

Danske Bank A S reduced its stake in Eli Lilly and Company (NYSE: LLY) by 9.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm …

California First Leasing Corp bought a new stake in Eli Lilly and Company (NYSE: LLY) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The…

Bernicke Wealth Management Ltd. purchased a new position in shares of Eli Lilly and Company (NYSE: LLY) in a recent quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm p…

LLY, NVO, VKTX and GPCR advance diabetes and obesity treatments, with promising drug candidates, expanding clinical studies and key pipeline milestones ahead.…

Facility will manufacture injectable medicines, including retatrutide Site will create 850 high-wage jobs and 2,000 construction jobs INDIANAPOLIS, Nov. 12, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today br…

Amid the broader tech sell-off following Nvidia (NVDA) CEO Jensen Huang's resignation, Dan Deming looks to healthcare and “anti-AI” plays for stability. He says he's following the momentum in stocks including Johnson & J…

The next wave of U.S. drug-price negotiations could put billions of dollars in pharmaceutical revenue under pressure, with Eli Lilly and Co (NYSE:LLY), Gilead Sciences, Inc. (NASDAQ:GILD) facing more immediate exposure a…

Nearly three times as many patients taking Taltz and Zepbound achieved ≥ 50% reduction in psoriatic arthritis disease activity (ACR50) at one year compared to Taltz alone in first-of-its-kind TOGETHER-PsA study Improveme…

In this monthly series, I rank a selection of dividend growth stocks and present the top 10 for consideration. To rank stocks, I sort candidates by quality score. This month's top 10, led by AMAT, LRCX, LLY, and AVGO, ar…

After years of thinking she should be able to manage her weight on her own, Leanne shares how a conversation with her doctor led her to Foundayo, and why she encourages others to talk with their healthcare providers INDI…

In adults with moderate-to-severe OSA and obesity or overweight, Foundayo reduced breathing interruptions during sleep by up to an average of 44%, with up to 32% of participants achieving remission or mild disease Found…

Agreement gives patients a path to FDA-approved treatments at self-pay price through the Hims & Hers platform INDIANAPOLIS, Nov. 6, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Hims & Hers Health, Inc. (NYS…

Pivotal results from the Phase 3 TRIUMPH-1 and TRIUMPH-4 trials showed retatrutide delivered substantial reductions in knee pain and weight in adults with knee osteoarthritis and obesity, with some experiencing no knee p…
Kept in their own lane. A press release is the company talking, not reporting.
Expected by Feb 1. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

